Literature DB >> 22812227

[Construction and expression of the recombinant plasmid pGEX-Sj14-3-3 of Schistosoma japonicum in BL21(DE3)].

Ning Zhang1, Wen-guia Li, Min Wang, Shi-fei Cai.   

Abstract

OBJECTIVE: To construct and research the expression of the recombinant plasmid pGEX-Sj14-3-3 in Escherichia coli BL21 (DE3).
METHODS: Sj14-3-3 gene was amplified by RT-PCR from template of the total RNA extracted from adult worms of S. japonicum, and then cloned into the vector pGEX-1gammaT to construct pGEX-Sj14-3-3. The recombinant plasmid pGEX-Sj14-3-3 was transformed into E. coli BL21 (DE3). BL21 (pGEX-Sj14-3-3) was induced with isopropyl-beta-D-thiogalactopyranosid (IPTG), and the expressed products were identified by SDS-PAGE and Western blot.
RESULTS: A 399 bp fragment of Sj14-3-3 coding gene was successfully amplified by RT-PCR and cloned into the vector pGEX-1gammaT, and the recombinant plasmid pGEX-Sj14-3-3 was constructded successfully. The molecular mass of the expressed recombinant protein was proximately 40 000 Dolton as detected by SDS-PAGE. The amount of the expressed protein was about 21% of the total bacterial protein. Western blot confirmed that the expressed protein could be recognized by the immune sera from rabbit infected with Schistosoma japonicum.
CONCLUSION: The recombinant plasmid pGEX-Sj14-3-3 was successfully constructed. The Sj14-3-3 protein was highly expressed in E. coli and the expressed recombinant protein possessed specific antigenicity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22812227

Source DB:  PubMed          Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-173X


  1 in total

1.  A recombinant Fasciola gigantica 14-3-3 epsilon protein (rFg14-3-3e) modulates various functions of goat peripheral blood mononuclear cells.

Authors:  Ai-Ling Tian; MingMin Lu; Guillermo Calderón-Mantilla; Evangelia Petsalaki; Tania Dottorini; XiaoWei Tian; YuJian Wang; Si-Yang Huang; Jun-Ling Hou; XiangRui Li; Hany M Elsheikha; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2018-03-06       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.